Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Publications

Paths of Progress 2023

  • Paths of Progress 2023 Cover The articles below are featured in the 2023 issue of our Paths of Progress magazine. To see the entire publication, which includes Dana-Farber's 2022 Annual Report, please download the PDF version.

    • One Drug, Two Targets

      Bispecific antibodies are new cancer drugs modeled after the body's own disease-fighting antibodies, but with a sort of superpower: They can bind to two different targets at one time.

    • Finding Pancreatic Cancer Earlier

      How Dana-Farber is transforming the narrative in the early detection and treatment of a stubborn cancer.

    • The Power of Plus

      Combining immunotherapy with other treatments shows great promise against certain cancers. Dana-Farber researchers are working to enhance its effectiveness, target more types of cancer, and lengthen remissions.

    • 50 Years of Stem Cell Transplants

      Five decades of scientific effort have made Dana-Farber a worldwide leader in stem cell transplants, transforming the lives of thousands of patients.

Posted on June 15, 2023

  • Media Contacts

    If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu.

    The Media Team cannot respond to patient inquiries. For more information, please see Contact Us.

  • Request a Publication

    Receive by mail the current issue of a Dana-Farber publication by completing this request form.